Protalix BioTherapeutics, Inc. Financial Ratios — PLX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.64	-14.44
Return on Assets (%)	-62.69	-17.8	-28.94	-31.24	66.1	-32.72	-108.04	-39.68	-34.31	-11.51	-38.96	-23.06	11.86	3.71	-8.48
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.57	6.78	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.58	4.81	- -
Gross Margin (%)	48.62	76.34	- -	82.12	83.27	8.71	27.74	72.83	80.08	82.71	57.37	58.87	64.91	54.46	48.82
EBITDA Margin (%)	-1,108.49	-24.63	- -	-721.52	-488.08	-338.95	-154.65	-51.51	-16.64	6.38	-50.44	-25.04	17.79	9.78	-7.65
Operating Margin (%)	-1,230.83	-35.36	- -	-810.64	-542.39	-360.51	-163.76	-56.39	-19.59	4.31	-53.36	-27.32	15.97	7.34	-10.43
Incremental Operating Margin (%)	- -	- -	63.59	- -	- -	- -	- -	- -	- -	163.64	- -	- -	131.46	54.1	- -
Pretax Margin (%)	-1,230.76	-33.75	- -	-945.16	-625.16	-317.16	-395.86	-77.27	-33.42	-10.37	-71.92	-30.22	13.08	7.78	-10.63
Profit Margin (%)	-1,230.76	-33.75	- -	-849.93	1,329.9	-319.22	-395.86	-77.27	-33.42	-10.37	-71.92	-31.33	12.69	5.49	-12.52
Net Income to Common Margin (%)	-1,230.76	-33.75	- -	-849.93	1,329.9	-319.22	-395.86	-77.27	-33.42	-10.37	-71.92	-31.33	12.69	5.49	-12.52
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.97	29.42	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.64	-14.44

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	67	67	72	73	52	48	61	64	33	33	26	6	8
ST Debt	- -	- -	- -	- -	- -	54	6	- -	5	60	1	1	22	2	1
LT Debt	- -	- -	67	67	72	19	46	48	55	4	32	32	5	4	7
Total Debt/EBITDA	- -	- -	-2.2	-2.65	-3.38	-2.35	-1.6	-2.72	-6.7	16.05	-1.73	-2.81	2.26	1.06	-2.06
Net Debt/EBITDA	0.82	6.14	0.63	-0.5	0.2	-0.32	-0.03	-0.58	-4.12	10.03	0.57	-0.93	-0.29	-3.78	3.64
Total Debt/EBIT	- -	- -	-1.97	-2.36	-3.05	-2.21	-1.51	-2.48	-5.68	23.76	-1.64	-2.57	2.51	1.41	-1.51
Net Debt/EBIT	0.74	4.27	0.57	-0.44	0.18	-0.3	-0.03	-0.53	-3.5	14.85	0.54	-0.85	-0.32	-5.04	2.67
EBITDA to Interest Expense	- -	-249.41	-28.66	-5.15	-5.7	-7.44	-3.35	-2.29	-1.14	0.41	-2.57	-4.72	3.66	4.92	-3.39
EBITDA-CapEx/Interest Expense	- -	-310.24	-30.44	-5.31	-5.83	-7.64	-3.45	-2.38	-1.22	0.35	-2.77	-4.96	3.3	3.71	-4.76
EBIT to Interest Expense	- -	-358	-31.98	-5.79	-6.34	-7.91	-3.55	-2.51	-1.35	0.28	-2.72	-5.15	3.29	3.69	-4.62
Interest Expense	- -	- -	1	5	4	4	10	8	8	10	8	3	3	1	1
Common Equity/Total Assets	-50.34	-4.26	-23.78	-70.96	11.18	-12.11	-40.79	-86.5	-154.92	-39.8	-8.19	-19.07	39.76	58.86	58.57
Long-Term Debt/Equity (%)	- -	- -	- -	- -	663.08	- -	- -	- -	- -	- -	- -	- -	13.77	9.32	14.38
Long-Term Debt/Capital (%)	- -	- -	167.19	573.2	86.9	30.58	203.54	-975.91	-590.45	11.96	117.6	141.7	7.72	8.26	12.27
Long-Term Debt/Total Assets (%)	- -	- -	59.16	85.95	74.13	23.52	64.07	78.46	122.24	6.58	43.8	58	5.47	5.48	8.42
Total Debt/Equity (%)	- -	- -	-248.82	-121.13	663.08	-735.31	-177.17	-90.71	-86.64	-238.19	-554.51	-314.61	78.29	12.79	17.25
Total Debt/Capital (%)	- -	- -	167.19	573.2	86.9	115.74	229.59	-975.91	-648.35	172.36	122	146.6	43.91	11.34	14.71
Total Debt/Total Assets (%)	- -	- -	59.16	85.95	74.13	89.02	72.27	78.46	134.22	94.8	45.44	60	31.13	7.53	10.1
Net Debt to Equity	103.54	1,550.04	71.81	-22.63	-39.34	-99.77	-3.48	-19.21	-53.28	-148.86	183.86	-104.1	-10.08	-45.73	-30.44
Net Debt/Capital (%)	50.87	93.94	41.8	-29.25	-64.84	-43,191.3	-3.61	-23.78	-137.8	210.74	96.08	193.53	-9.34	-68.19	-35.06
EBITDA	-33	-8	-31	-25	-21	-31	-33	-18	-9	4	-19	-12	12	5	-4
EBITDA-CapEx	-39	-11	-32	-26	-22	-32	-34	-18	-10	3	-21	-13	11	4	-6
Operating Income (Loss)	-37	-12	-34	-29	-24	-33	-35	-19	-11	3	-20	-13	10	4	-6

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.44	2.02	3.24	0.85	6.8	0.96	2.25	1.49	0.44	0.45	1.18	0.68	0.98	1.36	1.14
Current Ratio	1.74	2.38	3.67	1.02	7.64	1.09	2.75	2.09	0.81	0.64	1.86	1.38	1.54	2.34	2.51
Quick Ratio	1.52	2.08	3.31	0.88	6.8	0.97	2.32	1.68	0.56	0.47	1.28	0.83	1.09	1.47	1.47
CFO/Avg Current Liab	-1.25	0.03	-1.17	-0.64	-0.64	-0.83	-0.22	-0.32	-0.59	-0.41	-0.17	-0.76	-0.03	0.24	-0.46
Common Equity/Total Assets	-50.34	-4.26	-23.78	-70.96	11.18	-12.11	-40.79	-86.5	-154.92	-39.8	-8.19	-19.07	39.76	58.86	58.57
Long-Term Debt/Equity (%)	- -	- -	- -	- -	663.08	- -	- -	- -	- -	- -	- -	- -	13.77	9.32	14.38
Long-Term Debt/Capital (%)	- -	- -	167.19	573.2	86.9	30.58	203.54	-975.91	-590.45	11.96	117.6	141.7	7.72	8.26	12.27
Long-Term Debt/Total Assets (%)	- -	- -	59.16	85.95	74.13	23.52	64.07	78.46	122.24	6.58	43.8	58	5.47	5.48	8.42
Total Debt/Equity (%)	- -	- -	-248.82	-121.13	663.08	-735.31	-177.17	-90.71	-86.64	-238.19	-554.51	-314.61	78.29	12.79	17.25
Total Debt/Capital (%)	- -	- -	167.19	573.2	86.9	115.74	229.59	-975.91	-648.35	172.36	122	146.6	43.91	11.34	14.71
Total Debt/Total Assets (%)	- -	- -	59.16	85.95	74.13	89.02	72.27	78.46	134.22	94.8	45.44	60	31.13	7.53	10.1
CFO/Total Liabilities	-30.26	0.77	-21.85	-21.86	-28.11	-34.81	-9.83	-6.79	-16.73	-27.49	-12.9	-37.64	-2.59	28.72	-35.15
CFO/CapEx	-4.13	0.31	-16.22	-37.3	-52.34	-37.81	-10.29	-11.29	-30.87	-39.86	-7.05	-39.81	-1.15	6.77	-7.32
Altman's Z-Score	-3.35	0.75	-1.29	-4.68	-1.77	-4.4	-5.8	-7.08	-10.04	-5.85	-6.77	-8.77	-3.26	-2.92	-2.99

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	0.56	24.73	- -	1.77	4.63	26.55	17.46	10.62	11.6	18.78	14.09	11.87	13.29	13.05	8.98
Days Sales Outstanding	652.89	14.76	- -	205.91	78.79	13.75	20.9	34.38	31.46	19.44	25.9	30.76	27.47	27.96	40.65
Inventory Turnover	2.08	3.77	- -	0.11	0.16	1.53	2.33	1.13	1.3	1.02	1.05	1.13	1.28	1.21	1.15
Days Inventory Outstanding	175.68	96.76	- -	3,304.7	2,304.5	239.31	156.7	321.8	280.14	356.46	346.45	323.77	284.68	302.34	317.58
Accounts Payable Turnover	0.11	2.31	0.74	-0.85	0.82	2.06	3.09	1.58	1.79	2.3	2.99	2.87	4.95	5.99	6.43
Accounts Payable Turnover Days	3,354.44	157.89	490.07	-428	447.26	176.94	118.07	231.48	203.83	158.43	122.18	127.14	73.67	60.93	56.77
Cash Conversion Cycle	-2,525.87	-46.37	- -	3,938.61	1,936.03	76.12	59.54	124.7	107.77	217.47	250.17	227.38	238.47	269.37	301.46
Inventory to Cash Days	477.21	-82	- -	-3,098.78	-2,225.71	-225.56	-135.8	-287.42	-248.68	-337.02	-320.55	-293.02	-257.21	-274.38	-276.93
Inventories	- -	4	8	3	6	5	8	9	8	13	18	17	19	21	26
Raw Materials	- -	2	2	2	1	3	4	4	4	3	3	4	4	5	6
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	1	3	3	3	9	11	9
Finished Goods	- -	2	6	2	5	2	4	5	4	7	12	11	6	5	10
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	422	485	364	172	102	55	95	46	49	126	38	74	130	143	145
- Cash & Cash Equivalents	27	52	86	55	76	63	51	38	18	18	39	17	24	20	15
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	67	67	72	73	52	48	61	64	33	33	26	6	8
Enterprise Value	395	433	344	185	98	65	96	56	92	152	32	85	112	113	123
Total Capital	-26	-3	40	12	83	63	23	-5	-9	37	27	23	60	49	57
Total Debt/Capital (%)	- -	- -	167.19	573.2	86.9	115.74	229.59	-975.91	-648.35	172.36	122	146.6	43.91	11.34	14.71
Total Debt / EV	- -	- -	0.19	0.36	0.74	1.12	0.54	0.85	0.66	0.42	1.03	0.39	0.24	0.05	0.07
EV/Sales	133.14	12.58	- -	52.46	22.35	7.08	4.56	1.64	1.68	2.42	0.84	1.78	1.7	2.12	2.33
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	37.9	- -	- -	9.58	21.7	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	56.11	- -	- -	10.67	28.92	- -
EV/Cash Flow to Firm	- -	647.5	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	63.12	12.02	- -
EV/Free Cash Flow to Firm	- -	158.27	- -	- -	- -	- -	136.84	89.51	- -	- -	- -	- -	38.25	10.58	- -
Diluted Market Cap	417	471	359	171	97	45	87	46	49	106	37	66	147	152	141
Diluted Enterprise Value	390	419	340	184	93	55	88	56	92	152	31	83	149	138	135
EV per Share	46.15	46.33	36.83	19.74	9.77	5.25	6.68	3.79	6.19	4.37	0.71	1.58	1.53	1.49	1.53
TTM Sales	3	34	- -	4	4	9	21	34	55	63	38	48	65	53	53
TTM EBITDA	-33	-8	-31	-25	-21	-31	-33	-18	-9	4	-19	-12	12	5	-4
TTM Operating Income	-37	-12	-34	-29	-24	-33	-35	-19	-11	3	-20	-13	10	4	-6
TTM Cash Flow to Firm	-24	1	-30	-24	-21	-28	- -	- -	-11	-16	-3	-22	2	9	-11
TTM Free Cash Flow to Firm	-18	3	-28	-24	-20	-27	1	1	-11	-16	-1	-22	3	11	-9

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-23.36	174.43	-12.49	-6	-4.06	-1.44	-9.61	-6.49	-2.6	-4.16	-4.16	-2.72	-868.13	15.31	-13.65
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	56.11	- -	- -	10.67	28.92	- -
Enterprise Value	395	433	344	185	98	65	96	56	92	152	32	85	112	113	123
Low Price	40.6	47.1	37	17.1	7.4	2.6	3.82	2.7	1.7	2.04	0.79	0.7	1.21	0.82	1.32
EV/Sales	133.14	12.58	- -	52.46	22.35	7.08	4.56	1.64	1.68	2.42	0.84	1.78	1.7	2.12	2.33
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	37.9	- -	- -	9.58	21.7	- -
Price/Earnings	- -	- -	- -	- -	1.67	- -	- -	- -	- -	- -	- -	- -	14.46	46.51	- -
Price/Earnings Average	-15.03	-44.77	-16.74	-10.59	2.71	-2.35	-1.24	-2.88	-2.87	-15.56	-4.22	-3.48	15.19	31.74	-24.03
Price/Earnings High	-24.56	-60.21	-22.37	-16.44	3.93	-3.52	-2.38	-4.62	-4.87	-21.74	-11.23	-6.49	28.83	48.49	-36.87
Price/Earnings Low	-9.41	-36.83	-12.3	-5.3	1.21	-0.9	-0.6	-1.5	-1.38	-9.1	-1.26	-2.27	9.83	20.32	-15.7
Price/Book Value	-16.19	-144.54	-13.5	-3.1	9.36	-5.55	-3.23	-0.87	-0.69	-4.67	-6.28	-6.93	3.87	3.3	3
Price/Book Value Average	-21.3	-159.46	-17.48	-5.75	15.19	-8.48	-3.84	-1.45	-0.74	-4.48	-19.92	-5.42	4.06	2.25	3.37
Price/Book Value High	-34.81	-214.44	-23.35	-8.92	22.03	-12.72	-7.39	-2.33	-1.27	-6.26	-52.98	-10.11	7.71	3.44	5.17
Price/Book Value Low	-13.33	-131.17	-12.84	-2.88	6.79	-3.24	-1.86	-0.76	-0.36	-2.62	-5.96	-3.54	2.63	1.44	2.2
Price/Tangible Book Value	-16.19	-144.54	-13.5	-3.1	9.36	-5.55	-3.23	-0.87	-0.69	-4.67	-6.28	-6.93	3.87	3.3	3
Price/Tangible Book Value Average	-21.3	-159.46	-17.48	-5.75	15.19	-8.48	-3.84	-1.45	-0.74	-4.48	-19.92	-5.42	4.06	2.25	3.37
Price/Tangible Book Value High	-34.81	-214.44	-23.35	-8.92	22.03	-12.72	-7.39	-2.33	-1.27	-6.26	-52.98	-10.11	7.71	3.44	5.17
Price/Tangible Book Value Low	-13.33	-131.17	-12.84	-2.88	6.79	-3.24	-1.86	-0.76	-0.36	-2.62	-5.96	-3.54	2.63	1.44	2.2
Price/Sales	140.6	13.7	- -	48.52	22.19	4.9	4.11	1.34	0.89	1.68	0.96	1.39	1.83	2.55	2.68
Price/Sales Average	185.01	15.11	- -	90.05	35.99	7.5	4.9	2.23	0.96	1.61	3.04	1.09	1.93	1.74	3.01
Price/Sales High	302.3	20.32	- -	139.75	52.2	11.24	9.42	3.57	1.63	2.25	8.08	2.04	3.66	2.66	4.62
Price/Sales Low	115.79	12.43	- -	45.09	16.09	2.87	2.38	1.16	0.46	0.94	0.91	0.71	1.25	1.12	1.97
Price/Cash Flow	-17.7	742.5	-11.72	-5.84	-3.99	-1.41	-8.67	-5.91	-2.51	-4.05	-3.57	-2.66	-91.18	15.72	-11.79
Price/Cash Flow Average	-23.3	819.18	-15.18	-10.83	-6.47	-2.15	-10.33	-9.85	-2.71	-3.89	-11.33	-2.08	-95.8	10.73	-13.23
Price/Cash Flow High	-38.07	1,101.6	-20.28	-16.81	-9.38	-3.22	-19.87	-15.77	-4.6	-5.43	-30.13	-3.88	-181.84	16.39	-20.3
Price/Cash Flow Low	-14.58	673.83	-11.15	-5.42	-2.89	-0.82	-5.01	-5.13	-1.3	-2.27	-3.39	-1.36	-61.98	6.87	-8.65
Price/Free Cash Flow Average	-30.74	192.45	-16.18	-11.13	-6.59	-2.21	-11.45	-10.81	-2.8	-3.99	-13.2	-2.13	-912.11	10.44	-15.33
Price/Free Cash Flow High	-50.22	258.79	-21.61	-17.28	-9.56	-3.31	-22	-17.31	-4.75	-5.57	-35.11	-3.98	-1,731.39	15.96	-23.51
Price/Free Cash Flow Low	-19.24	158.3	-11.88	-5.57	-2.95	-0.84	-5.55	-5.63	-1.35	-2.33	-3.95	-1.39	-590.14	6.69	-10.01
EV/Sales Average	178.07	14.04	- -	94.31	36.86	10.26	5.42	2.54	1.75	2.66	2.99	1.55	2.12	1.56	2.96
EV/Sales High	296.72	19.4	- -	144.39	53.91	14.84	10.38	3.89	2.42	3.42	8.2	2.6	3.99	2.52	4.61
EV/Sales Low	108.04	11.28	- -	49.01	15.94	4.59	2.65	1.47	1.25	1.86	0.79	1.13	1.39	0.9	1.89
EV/EBITDA Average	-16.06	-56.99	-14.8	-13.07	-7.55	-3.03	-3.51	-4.94	-10.5	41.68	-5.93	-6.21	11.94	15.91	-38.7
EV/EBITDA High	-26.77	-78.75	-19.98	-20.01	-11.04	-4.38	-6.71	-7.56	-14.52	53.66	-16.25	-10.39	22.46	25.75	-60.21
EV/EBITDA Low	-9.75	-45.79	-10.7	-6.79	-3.27	-1.35	-1.72	-2.85	-7.51	29.14	-1.58	-4.53	7.8	9.21	-24.73
EV/EBIT Average	-14.47	-39.7	-13.26	-11.63	-6.8	-2.85	-3.31	-4.51	-8.91	61.7	-5.61	-5.69	13.3	21.21	-28.39
EV/EBIT High	-24.11	-54.87	-17.9	-17.81	-9.94	-4.12	-6.34	-6.9	-12.33	79.43	-15.36	-9.52	25.01	34.32	-44.17
EV/EBIT Low	-8.78	-31.9	-9.59	-6.05	-2.94	-1.27	-1.62	-2.6	-6.38	43.15	-1.49	-4.15	8.69	12.27	-18.15
Last Price	49.3	51.9	38.9	18.4	10.2	4.45	6.61	3.11	3.28	3.63	0.83	1.37	1.78	1.88	1.8
High Price	106	77	67.3	53	24	10.2	15.15	8.3	6	4.86	7.02	2	3.55	1.96	3.1
Enterprise Value Average	529	483	452	332	161	94	114	87	96	167	115	74	139	83	156
Enterprise Value High	881	668	610	509	235	137	219	133	132	215	314	124	262	134	243
Enterprise Value Low	321	388	327	173	70	42	56	50	68	117	30	54	91	48	100

Shares Outstanding	9	9	9	9	10	12	14	15	15	35	46	54	73	76	80
Diluted Weighted Avg Shares	8	9	9	9	9	10	13	15	15	29	44	48	82	81	79
Basic Weighted Avg Shares	8	9	9	9	9	10	13	15	15	29	44	48	68	73	79
Revenue per Share	0.35	3.79	- -	0.38	0.46	0.91	1.61	2.33	3.69	2.16	0.87	0.98	0.97	0.74	0.67
EBITDA per Share	-3.89	-0.93	-3.3	-2.74	-2.24	-3.08	-2.49	-1.2	-0.61	0.14	-0.44	-0.25	0.17	0.07	-0.05
Operating Income per Share	-4.32	-1.34	-3.69	-3.07	-2.49	-3.27	-2.63	-1.31	-0.72	0.09	-0.46	-0.27	0.15	0.05	-0.07
Basic EPS, GAAP	-4.32	-1.28	-3.01	-3.22	6.11	-2.9	-6.37	-1.8	-1.23	-0.22	-0.62	-0.31	0.12	0.04	-0.08
Basic EPS from Cont Ops	-4.32	-1.28	-3.76	-3.58	-2.87	-2.88	-6.37	-1.8	-1.23	-0.22	-0.62	-0.31	0.12	0.04	-0.08
Diluted EPS, GAAP	-4.32	-1.28	-3.01	-3.22	6.11	-2.9	-6.37	-1.8	-1.23	-0.22	-0.62	-0.31	0.1	0.04	-0.08
Diluted EPS from Cont Ops	-4.32	-1.28	-3.76	-3.58	-2.87	-2.88	-6.37	-1.8	-1.23	-0.22	-0.62	-0.31	0.1	0.04	-0.08
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.78	0.07	-3.32	-3.15	-2.56	-3.17	-0.76	-0.53	-1.3	-0.9	-0.23	-0.52	-0.02	0.12	-0.15
Free Cash Flow per Basic Share	-3.46	-0.16	-3.52	-3.24	-2.61	-3.25	-0.84	-0.57	-1.35	-0.92	-0.27	-0.53	-0.04	0.1	-0.17
Cash & Equivalents per Share	3.15	5.57	9.24	5.85	7.65	5.1	3.56	2.55	1.2	1.11	0.86	0.41	0.61	0.46	0.38
Book Value per Share	-3.05	-0.36	-2.88	-5.94	1.09	-0.8	-2.05	-3.56	-4.74	-0.78	-0.13	-0.2	0.46	0.57	0.6
Tangible Book Value per Share	-3.05	-0.36	-2.88	-5.94	1.09	-0.8	-2.05	-3.56	-4.74	-0.78	-0.13	-0.2	0.46	0.57	0.6

Protalix BioTherapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)